Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy
Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, foll...
Saved in:
Published in | Journal of controlled release Vol. 359; pp. 347 - 358 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O6-BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O6-BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies.
PLGA-based bioinspired platform for tumor-specific retention and enhanced colorectal cancer therapy. [Display omitted] |
---|---|
AbstractList | Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O6-benzylguanine (O6-BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O6-BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O6-BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies.
PLGA-based bioinspired platform for tumor-specific retention and enhanced colorectal cancer therapy. [Display omitted] Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for macrophages-targeted delivery of TMZ and O -benzylguanine (O -BG). TMZ was loaded in poly (D, l-lactide-coglycolide) (PLGA) nanoparticles, followed by sequential coating with O -BG-grafted chitosan (BG-CS) layers and yeast shell walls (YSW) via layer-by-layer assembly (LBL) process, forming TMZ@P-BG/YSW biohybrids. Due to the yeast cell membrane-camouflage, TMZ@P-BG/YSW particles exhibited significantly enhanced colloidal stability as well as low premature drug leakage in simulated gastrointestinal conditions. In vitro drug release profiles of TMZ@P-BG/YSW particles revealed noticeable higher TMZ release in simulated tumor acidic environment within 72 h. Meanwhile, O -BG could down-regulate MGMT expression in CT26 colon carcinoma cells, ultimately facilitating TMZ-induced tumor cell death. After oral delivery of yeast cell membrane-camouflaged particles containing fluorescent tracer (Cy5), TMZ@P-BG/YSW and bare YSW displayed high retention time of 12 h in the colon and small intestine (ileum). Correspondingly, oral gavage administration of TMZ@P-BG/YSW particles afforded favorable tumor-specific retention and superior tumor growth inhibition. Overall, TMZ@P-BG/YSW is validated to be a safe, targetable and effective formulation, paving a new avenue towards highly effective and precise treatment of malignancies. |
Author | Liu, Wen-Long Chen, Qi-Wen Yu, Jin-Xin Chen, Xiao-Sui Cheng, Yin-Jia Zhang, Ai-Qing Qin, Si-Yong Ma, Yi-Han He, Yu Zhang, Xian-Zheng |
Author_xml | – sequence: 1 givenname: Yu surname: He fullname: He, Yu organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 2 givenname: Qi-Wen surname: Chen fullname: Chen, Qi-Wen organization: Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry Wuhan University, Wuhan 430072, People's Republic of China – sequence: 3 givenname: Jin-Xin surname: Yu fullname: Yu, Jin-Xin organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 4 givenname: Si-Yong surname: Qin fullname: Qin, Si-Yong organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 5 givenname: Wen-Long surname: Liu fullname: Liu, Wen-Long organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 6 givenname: Yi-Han surname: Ma fullname: Ma, Yi-Han organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 7 givenname: Xiao-Sui surname: Chen fullname: Chen, Xiao-Sui organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 8 givenname: Ai-Qing surname: Zhang fullname: Zhang, Ai-Qing organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China – sequence: 9 givenname: Xian-Zheng surname: Zhang fullname: Zhang, Xian-Zheng organization: Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry Wuhan University, Wuhan 430072, People's Republic of China – sequence: 10 givenname: Yin-Jia surname: Cheng fullname: Cheng, Yin-Jia email: ChengYJ@mail.scuec.edu.cn organization: Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, School of Chemistry and Materials Science, South-Central Minzu University, Wuhan 430074, People's Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37277054$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1LxDAQhoMouqv-BKVHL635bnuSZdFVWNCDCp5Cmk60S9vUpCv4703Z1aswZC7PzOR95uiwdz0gdEFwRjCR15tsY1zvoc0opizDIsOcHaAZKXKW8rIUh2gWuSJlUpQnaB7CBmMsGM-P0QnLaZ5jwWfo9Q10GBMDbZt00FVe95Aa3bmtbfU71MnTerVIet27QfuxMS0kQ6tH63yXxCeB_kP3JnJmaj4ZP8Dr4fsMHVndBjjf91P0cnf7vLxP14-rh-VinZr4rTEVOZOFtYZKUxtdVsSWXJYVFTWLJaUtpK2sIKXhnOgaWFlQgo2sWW254Iadoqvd3sG7zy2EUXVNmMLEGG4bFC0ow5zmkkZU7FDjXQgerBp802n_rQhWk1K1UXulalKqsFBRaZy73J_YVh3Uf1O_DiNwswMgBv1qwKtgGpikNB7MqGrX_HPiB2DZjMQ |
CitedBy_id | crossref_primary_10_1021_accountsmr_4c00116 crossref_primary_10_1016_j_cclet_2024_109657 crossref_primary_10_1016_j_jddst_2024_105812 crossref_primary_10_4155_tde_2023_0027 |
Cites_doi | 10.1038/sj.bjc.6604366 10.1016/j.mattod.2017.05.006 10.1016/j.foodhyd.2020.106284 10.3389/fvets.2020.00042 10.6023/cjoc201803050 10.1016/j.ijbiomac.2020.07.228 10.7150/thno.35353 10.1016/j.biomaterials.2013.07.097 10.1002/cncr.33349 10.1016/j.addr.2011.12.009 10.3390/biom13050768 10.3390/polym13203471 10.1080/1061186X.2016.1238091 10.1016/j.ijpharm.2009.07.005 10.1021/acs.molpharmaceut.8b00957 10.1126/sciadv.abf0677 10.1182/blood-2004-03-1140 10.1016/j.ejpb.2015.06.014 10.1021/acsnano.2c02540 10.1016/j.ijbiomac.2022.08.173 10.1007/s10118-022-2726-0 10.7150/thno.38081 10.1016/j.carbpol.2016.12.009 10.3748/wjg.v17.i13.1666 10.1016/j.cej.2017.02.003 10.1002/med.21809 10.1002/adma.202100701 10.1053/j.gastro.2008.02.098 10.1158/1538-7445.AM2018-CT095 10.3945/ajcn.2008.26701 10.1002/smtd.202100951 10.1093/abbs/gmq125 10.1038/nature07774 10.1002/adfm.202009733 10.1021/nn503735w 10.3109/08941939709032139 10.1016/j.reactfunctpolym.2019.104459 10.1016/j.redox.2020.101495 10.1016/j.carbpol.2020.117255 10.18632/oncotarget.7896 10.1007/s00894-016-3133-7 10.1016/j.ijbiomac.2016.08.080 |
ContentType | Journal Article |
Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.jconrel.2023.05.043 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4995 |
EndPage | 358 |
ExternalDocumentID | 10_1016_j_jconrel_2023_05_043 37277054 S0168365923003565 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACNNM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 D-I DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SCC SDF SDG SDP SES SEW SPC SPCBC SPT SSM SSP SSZ T5K TEORI WUQ ~G- AAHBH AAXKI AFJKZ AKRWK NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c365t-57368ffc26cdca9b1f9469b25d35d366f86fbf519c441ade398210c6d3df454c3 |
IEDL.DBID | AIKHN |
ISSN | 0168-3659 |
IngestDate | Fri Aug 16 10:19:42 EDT 2024 Thu Sep 26 19:15:51 EDT 2024 Sat Sep 28 08:10:22 EDT 2024 Fri Feb 23 02:34:21 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Colorectal cancer therapy Oral drug delivery system PLGA Temozolomide Tumor-specific accumulation Yeast shell wall |
Language | English |
License | Copyright © 2023 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c365t-57368ffc26cdca9b1f9469b25d35d366f86fbf519c441ade398210c6d3df454c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 37277054 |
PQID | 2823042762 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2823042762 crossref_primary_10_1016_j_jconrel_2023_05_043 pubmed_primary_37277054 elsevier_sciencedirect_doi_10_1016_j_jconrel_2023_05_043 |
PublicationCentury | 2000 |
PublicationDate | July 2023 2023-Jul 2023-07-00 20230701 |
PublicationDateYYYYMMDD | 2023-07-01 |
PublicationDate_xml | – month: 07 year: 2023 text: July 2023 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of controlled release |
PublicationTitleAlternate | J Control Release |
PublicationYear | 2023 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Han, Yin, Ye, Tan, Shi, He, Wang, Wu, Ye, Guo (bb0070) 2018; 38 Verma, Gokhale, Burgess (bb0105) 2009; 380 Morano, Corallo, Barault, Niger, Berenato, Moretto, Fucà, Randon, Antista, Belfiore (bb0035) 2018; 78 Lin, Mukherjee, Li, Hou, Pan, Liu (bb0185) 2021; 7 Larrea, Clemente, Luque-Michel, Sebastian (bb0110) 2017; 316 Pei, Jia, Li, Liu (bb0140) 2018; 16 Wang, Sun, Fan, Du (bb0020) 2022; 40 Herre, Marshall, Caron, Edwards, Williams, Schweighoffer, Tybulewicz, Sousa, Gordon, Brown (bb0165) 2004; 104 Miao, Chen, Chen, Mi, Lin, Chang, Chiang, Wang, Lin, Sung (bb0100) 2021; 33 Kang, Choi, Lee, Lee, Kim, Jang, Tunsirikongkon, Kim, Park (bb0075) 2017; 159 Stephen, Kievit, Veiseh, Chiarelli, Fang, Wang, Hatzinger, Ellenbogen, Silber, Zhang (bb0045) 2014; 8 Qian, Zheng, Wang, Tang, Zhang, Zhang, Huang, Pei, Jiang (bb0055) 2013; 34 Frank, Onzi, Morawski, Pohlmann, Guterres, Contri (bb0080) 2020; 147 Sipos, Műzes (bb0090) 2011; 17 Zhou, Ling, Liu, Zhang, Ding, Dong, Liang, Li, Zhang (bb0215) 2019; 9 Zhang, Xu, Chen, Dou, Zhou, Li, Li, An, Tao, Hu (bb0220) 2017; 20 Chai, Liu, Tian, Li, Tang (bb0015) 2011; 43 Kim, Patel, Patel (bb0060) 2021; 13 Esquivel, Bhatt, Diwan, Habib, Lee, Khatun, Nurunnabi (bb0195) 2023; 13 Qin, Xie, Xue, Li, Gan, Zhu, Sun (bb0155) 2021; 112 Thakur, Thotakura, Kumar, Kumar, Singh, Chitkara, Raza (bb0120) 2016; 93 Saxena, Thompson, Sharp (bb0095) 1997; 10 Yu, Chen, Guo, Wang, Feng, Kong, Hong (bb0130) 2015; 10 Liu, Yao, Li, Wang, Jiang (bb0050) 2017; 25 Aouadi, Tesz, Nicoloro, Wang, Chouinard, Soto, Ostroff, Czech (bb0125) 2009; 458 Chugh, Ballman, Helman, Patel, Whelan, Widemann, Lu, Hawkins, Mascarenhas, Glod (bb0160) 2021; 127 Khalilian, Mirzaei, Taherpour (bb0145) 2016; 22 Zheng, Zhang, Liu, Wang, Cui, Pan, Liu, Tang, Wang (bb0200) 2021; 253 Peters, Boers, Haddeman, Melnikov, Qvyjt (bb0210) 2009; 89 Wolpin, Mayer (bb0010) 2008; 134 Khan, Ranson, Michael, Olver, Levitt, Mortimer, Watson, Margison, Midgley, Middleton (bb0040) 2008; 98 Faraji Dizaji, Hasani Azerbaijan, Sheisi, Goleij, Mirmajidi, Chogan, Irani, Sharafian (bb0065) 2020; 164 Ensign, Cone, Hanes (bb0180) 2012; 64 Zhang, Zheng, Li, Pan, Zeng, Pan, Zhang (bb0025) 2022; 6 Wang, Wu, Lu, Jiang, Yu (bb0085) 2020; 7 Han, Luo, Ye, Hu, Fu, Gao, Fu, Gao (bb0190) 2022; 219 Chen, Han, Zhao, Tang, Wang (bb0135) 2019; 9 Fan, Chen, Hou, Chuan, Mu, Liu, Liang, Guo, Xu (bb0170) 2021; 31 Xu, Shen, Li, Sun, Teng, Wang, Duan (bb0115) 2016; 7 Wang, Liu, Liu, Li, He, Yin, Tu, Shen, Bai, Wang (bb0205) 2020; 32 Khan, Albalawi, Pottoo (bb0005) 2022; 42 Han, Xie, Li, Shi, Wan, Chen, Wang (bb0030) 2019; 9 Zhao, Liu, He, Dong, Zhang, Xu, Kang, Xue (bb0150) 2022; 16 Ma, Fuchs, Boase, Rolfe, Coombes, Thurecht (bb0175) 2015; 94 Liu (10.1016/j.jconrel.2023.05.043_bb0050) 2017; 25 Miao (10.1016/j.jconrel.2023.05.043_bb0100) 2021; 33 Aouadi (10.1016/j.jconrel.2023.05.043_bb0125) 2009; 458 Stephen (10.1016/j.jconrel.2023.05.043_bb0045) 2014; 8 Yu (10.1016/j.jconrel.2023.05.043_bb0130) 2015; 10 Wang (10.1016/j.jconrel.2023.05.043_bb0020) 2022; 40 Larrea (10.1016/j.jconrel.2023.05.043_bb0110) 2017; 316 Han (10.1016/j.jconrel.2023.05.043_bb0030) 2019; 9 Sipos (10.1016/j.jconrel.2023.05.043_bb0090) 2011; 17 Kang (10.1016/j.jconrel.2023.05.043_bb0075) 2017; 159 Fan (10.1016/j.jconrel.2023.05.043_bb0170) 2021; 31 Zhao (10.1016/j.jconrel.2023.05.043_bb0150) 2022; 16 Frank (10.1016/j.jconrel.2023.05.043_bb0080) 2020; 147 Chai (10.1016/j.jconrel.2023.05.043_bb0015) 2011; 43 Peters (10.1016/j.jconrel.2023.05.043_bb0210) 2009; 89 Morano (10.1016/j.jconrel.2023.05.043_bb0035) 2018; 78 Pei (10.1016/j.jconrel.2023.05.043_bb0140) 2018; 16 Zhang (10.1016/j.jconrel.2023.05.043_bb0220) 2017; 20 Verma (10.1016/j.jconrel.2023.05.043_bb0105) 2009; 380 Chen (10.1016/j.jconrel.2023.05.043_bb0135) 2019; 9 Xu (10.1016/j.jconrel.2023.05.043_bb0115) 2016; 7 Herre (10.1016/j.jconrel.2023.05.043_bb0165) 2004; 104 Ma (10.1016/j.jconrel.2023.05.043_bb0175) 2015; 94 Khan (10.1016/j.jconrel.2023.05.043_bb0005) 2022; 42 Wolpin (10.1016/j.jconrel.2023.05.043_bb0010) 2008; 134 Zhang (10.1016/j.jconrel.2023.05.043_bb0025) 2022; 6 Wang (10.1016/j.jconrel.2023.05.043_bb0205) 2020; 32 Chugh (10.1016/j.jconrel.2023.05.043_bb0160) 2021; 127 Khalilian (10.1016/j.jconrel.2023.05.043_bb0145) 2016; 22 Faraji Dizaji (10.1016/j.jconrel.2023.05.043_bb0065) 2020; 164 Esquivel (10.1016/j.jconrel.2023.05.043_bb0195) 2023; 13 Thakur (10.1016/j.jconrel.2023.05.043_bb0120) 2016; 93 Zheng (10.1016/j.jconrel.2023.05.043_bb0200) 2021; 253 Wang (10.1016/j.jconrel.2023.05.043_bb0085) 2020; 7 Kim (10.1016/j.jconrel.2023.05.043_bb0060) 2021; 13 Saxena (10.1016/j.jconrel.2023.05.043_bb0095) 1997; 10 Qian (10.1016/j.jconrel.2023.05.043_bb0055) 2013; 34 Han (10.1016/j.jconrel.2023.05.043_bb0190) 2022; 219 Lin (10.1016/j.jconrel.2023.05.043_bb0185) 2021; 7 Qin (10.1016/j.jconrel.2023.05.043_bb0155) 2021; 112 Ensign (10.1016/j.jconrel.2023.05.043_bb0180) 2012; 64 Zhou (10.1016/j.jconrel.2023.05.043_bb0215) 2019; 9 Han (10.1016/j.jconrel.2023.05.043_bb0070) 2018; 38 Khan (10.1016/j.jconrel.2023.05.043_bb0040) 2008; 98 |
References_xml | – volume: 34 start-page: 8968 year: 2013 ident: bb0055 article-title: Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy publication-title: Biomaterials contributor: fullname: Jiang – volume: 13 start-page: 768 year: 2023 ident: bb0195 article-title: β-Glucan and fatty acid based mucoadhesive carrier for gastrointestinal tract specific local and sustained drug delivery publication-title: Biomolecules contributor: fullname: Nurunnabi – volume: 159 start-page: 39 year: 2017 ident: bb0075 article-title: Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles publication-title: Carbohydr. Polym. contributor: fullname: Park – volume: 112 year: 2021 ident: bb0155 article-title: Effect of acid and oxidative degradation on the structural, rheological, and physiological properties of oat β-glucan publication-title: Food Hydrocoll. contributor: fullname: Sun – volume: 42 start-page: 227 year: 2022 ident: bb0005 article-title: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment publication-title: Med. Res. Rev. contributor: fullname: Pottoo – volume: 94 start-page: 393 year: 2015 ident: bb0175 article-title: The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: evaluation of their potential for colon-specific delivery publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Thurecht – volume: 16 start-page: 227 year: 2018 ident: bb0140 article-title: Versatile polymeric microspheres with tumor microenvironment bioreducible degradation, pH-activated surface charge reversal, pH-triggered “off-on” fluorescence and drug release as theranostic nanoplatforms publication-title: Mol. Pharm. contributor: fullname: Liu – volume: 13 start-page: 3471 year: 2021 ident: bb0060 article-title: PLGA core-shell nano/microparticle delivery system for biomedical application publication-title: Polymers contributor: fullname: Patel – volume: 127 start-page: 1301 year: 2021 ident: bb0160 article-title: SARC025 arms 1 and 2: a phase 1 study of the poly (ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma publication-title: Cancer contributor: fullname: Glod – volume: 93 start-page: 381 year: 2016 ident: bb0120 article-title: Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen publication-title: Int. J. Biol. Macromol. contributor: fullname: Raza – volume: 147 year: 2020 ident: bb0080 article-title: Chitosan as a coating material for nanoparticles intended for biomedical applications publication-title: React. Funct. Polym. contributor: fullname: Contri – volume: 7 start-page: 42 year: 2020 ident: bb0085 article-title: promotes intestinal development and regulates mucosal immune function in newborn piglets publication-title: Front. Vet. Sci. contributor: fullname: Yu – volume: 9 start-page: 1 year: 2019 ident: bb0135 article-title: Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release publication-title: Sci. Rep. contributor: fullname: Wang – volume: 38 start-page: 2706 year: 2018 ident: bb0070 article-title: Preparation of poly (lactic-co-glycolic acid)/polyethylene glycol nanoparticles with surface-modified aptamer S6 and its application on carrier siRNA publication-title: Chin. J. Org. Chem. contributor: fullname: Guo – volume: 380 start-page: 216 year: 2009 ident: bb0105 article-title: A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions publication-title: Int. J. Pharm. contributor: fullname: Burgess – volume: 16 start-page: 12118 year: 2022 ident: bb0150 article-title: Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment publication-title: ACS Nano contributor: fullname: Xue – volume: 33 year: 2021 ident: bb0100 article-title: A noninvasive gut-to-brain oral drug delivery system for treating brain tumors publication-title: Adv. Mater. contributor: fullname: Sung – volume: 134 start-page: 1296 year: 2008 ident: bb0010 article-title: Systemic treatment of colorectal cancer publication-title: Gastroenterology contributor: fullname: Mayer – volume: 17 start-page: 1666 year: 2011 ident: bb0090 article-title: Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? publication-title: World J. Gastroenterol. contributor: fullname: Műzes – volume: 64 start-page: 557 year: 2012 ident: bb0180 article-title: Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Hanes – volume: 32 year: 2020 ident: bb0205 article-title: Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis publication-title: Redox Biol. contributor: fullname: Wang – volume: 9 start-page: 7458 year: 2019 ident: bb0030 article-title: Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer publication-title: Theranostics contributor: fullname: Wang – volume: 7 start-page: eabf0677 year: 2021 ident: bb0185 article-title: Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches publication-title: Sci. Adv. contributor: fullname: Liu – volume: 10 start-page: 97 year: 1997 ident: bb0095 article-title: Role of organized intestinal lymphoid aggregates in intestinal regeneration publication-title: J. Investig. Surg. contributor: fullname: Sharp – volume: 20 start-page: 301 year: 2017 ident: bb0220 article-title: Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease publication-title: Mater. Today contributor: fullname: Hu – volume: 7 start-page: 20890 year: 2016 ident: bb0115 article-title: The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells publication-title: Oncotarget contributor: fullname: Duan – volume: 89 start-page: 58 year: 2009 ident: bb0210 article-title: No effect of added β-glucan or of fructooligosaccharide on appetite or energy intake publication-title: Am. J. Clin. Nutr. contributor: fullname: Qvyjt – volume: 458 start-page: 1180 year: 2009 ident: bb0125 article-title: Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation publication-title: Nature contributor: fullname: Czech – volume: 104 start-page: 4038 year: 2004 ident: bb0165 article-title: Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages publication-title: Blood contributor: fullname: Brown – volume: 25 start-page: 235 year: 2017 ident: bb0050 article-title: iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy publication-title: J. Drug Target. contributor: fullname: Jiang – volume: 219 start-page: 1244 year: 2022 ident: bb0190 article-title: Research progress on natural β-glucan in intestinal diseases publication-title: Int. J. Biol. Macromol. contributor: fullname: Gao – volume: 78 start-page: CT095 year: 2018 ident: bb0035 article-title: Abstract CT095: Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients (pts) bearing MGMT methylation publication-title: Cancer Res. contributor: fullname: Belfiore – volume: 9 start-page: 6568 year: 2019 ident: bb0215 article-title: Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route publication-title: Theranostics contributor: fullname: Zhang – volume: 164 start-page: 1461 year: 2020 ident: bb0065 article-title: Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of paclitaxel toward prostate cancer cells death publication-title: Int. J. Biol. Macromol. contributor: fullname: Sharafian – volume: 98 start-page: 1614 year: 2008 ident: bb0040 article-title: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer publication-title: Br. J. Cancer contributor: fullname: Middleton – volume: 22 start-page: 1 year: 2016 ident: bb0145 article-title: The simulation of UV spectroscopy and electronic analysis of temozolomide and dacarbazine chemical decomposition to their metabolites publication-title: J. Mol. Model. contributor: fullname: Taherpour – volume: 8 start-page: 10383 year: 2014 ident: bb0045 article-title: Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors publication-title: ACS Nano contributor: fullname: Zhang – volume: 316 start-page: 663 year: 2017 ident: bb0110 article-title: Efficient production of hybrid bio-nanomaterials by continuous microchannel emulsification: dye-doped SiO2 and Au-PLGA nanoparticles publication-title: Chem. Eng. J. contributor: fullname: Sebastian – volume: 43 start-page: 217 year: 2011 ident: bb0015 article-title: MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines publication-title: Acta Biochim. Biophys. Sin. contributor: fullname: Tang – volume: 10 start-page: 1743 year: 2015 ident: bb0130 article-title: Specifically targeted delivery of protein to phagocytic macrophages publication-title: Int. J. Nanomedicine contributor: fullname: Hong – volume: 253 year: 2021 ident: bb0200 article-title: Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase publication-title: Carbohydr. Polym. contributor: fullname: Wang – volume: 31 start-page: 2009733 year: 2021 ident: bb0170 article-title: Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy publication-title: Adv. Funct. Mater. contributor: fullname: Xu – volume: 40 start-page: 1154 year: 2022 ident: bb0020 article-title: Intestine enzyme-responsive polysaccharide-based hydrogel to open epithelial tight junctions for oral delivery of Imatinib against colon cancer publication-title: Chin. J. Polym. Sci. contributor: fullname: Du – volume: 6 start-page: 2100951 year: 2022 ident: bb0025 article-title: Temulence therapy to orthotopic colorectal tumor via oral administration of fungi-based acetaldehyde generator publication-title: Small Methods contributor: fullname: Zhang – volume: 98 start-page: 1614 year: 2008 ident: 10.1016/j.jconrel.2023.05.043_bb0040 article-title: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6604366 contributor: fullname: Khan – volume: 20 start-page: 301 year: 2017 ident: 10.1016/j.jconrel.2023.05.043_bb0220 article-title: Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease publication-title: Mater. Today doi: 10.1016/j.mattod.2017.05.006 contributor: fullname: Zhang – volume: 112 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0155 article-title: Effect of acid and oxidative degradation on the structural, rheological, and physiological properties of oat β-glucan publication-title: Food Hydrocoll. doi: 10.1016/j.foodhyd.2020.106284 contributor: fullname: Qin – volume: 7 start-page: 42 year: 2020 ident: 10.1016/j.jconrel.2023.05.043_bb0085 article-title: Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets publication-title: Front. Vet. Sci. doi: 10.3389/fvets.2020.00042 contributor: fullname: Wang – volume: 38 start-page: 2706 year: 2018 ident: 10.1016/j.jconrel.2023.05.043_bb0070 article-title: Preparation of poly (lactic-co-glycolic acid)/polyethylene glycol nanoparticles with surface-modified aptamer S6 and its application on carrier siRNA publication-title: Chin. J. Org. Chem. doi: 10.6023/cjoc201803050 contributor: fullname: Han – volume: 164 start-page: 1461 year: 2020 ident: 10.1016/j.jconrel.2023.05.043_bb0065 article-title: Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of paclitaxel toward prostate cancer cells death publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.07.228 contributor: fullname: Faraji Dizaji – volume: 9 start-page: 6568 year: 2019 ident: 10.1016/j.jconrel.2023.05.043_bb0215 article-title: Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route publication-title: Theranostics doi: 10.7150/thno.35353 contributor: fullname: Zhou – volume: 34 start-page: 8968 year: 2013 ident: 10.1016/j.jconrel.2023.05.043_bb0055 article-title: Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.07.097 contributor: fullname: Qian – volume: 127 start-page: 1301 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0160 article-title: SARC025 arms 1 and 2: a phase 1 study of the poly (ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma publication-title: Cancer doi: 10.1002/cncr.33349 contributor: fullname: Chugh – volume: 64 start-page: 557 year: 2012 ident: 10.1016/j.jconrel.2023.05.043_bb0180 article-title: Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2011.12.009 contributor: fullname: Ensign – volume: 13 start-page: 768 year: 2023 ident: 10.1016/j.jconrel.2023.05.043_bb0195 article-title: β-Glucan and fatty acid based mucoadhesive carrier for gastrointestinal tract specific local and sustained drug delivery publication-title: Biomolecules doi: 10.3390/biom13050768 contributor: fullname: Esquivel – volume: 13 start-page: 3471 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0060 article-title: PLGA core-shell nano/microparticle delivery system for biomedical application publication-title: Polymers doi: 10.3390/polym13203471 contributor: fullname: Kim – volume: 25 start-page: 235 year: 2017 ident: 10.1016/j.jconrel.2023.05.043_bb0050 article-title: iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy publication-title: J. Drug Target. doi: 10.1080/1061186X.2016.1238091 contributor: fullname: Liu – volume: 380 start-page: 216 year: 2009 ident: 10.1016/j.jconrel.2023.05.043_bb0105 article-title: A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2009.07.005 contributor: fullname: Verma – volume: 16 start-page: 227 year: 2018 ident: 10.1016/j.jconrel.2023.05.043_bb0140 article-title: Versatile polymeric microspheres with tumor microenvironment bioreducible degradation, pH-activated surface charge reversal, pH-triggered “off-on” fluorescence and drug release as theranostic nanoplatforms publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.8b00957 contributor: fullname: Pei – volume: 7 start-page: eabf0677 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0185 article-title: Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches publication-title: Sci. Adv. doi: 10.1126/sciadv.abf0677 contributor: fullname: Lin – volume: 104 start-page: 4038 year: 2004 ident: 10.1016/j.jconrel.2023.05.043_bb0165 article-title: Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages publication-title: Blood doi: 10.1182/blood-2004-03-1140 contributor: fullname: Herre – volume: 94 start-page: 393 year: 2015 ident: 10.1016/j.jconrel.2023.05.043_bb0175 article-title: The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: evaluation of their potential for colon-specific delivery publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2015.06.014 contributor: fullname: Ma – volume: 16 start-page: 12118 year: 2022 ident: 10.1016/j.jconrel.2023.05.043_bb0150 article-title: Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment publication-title: ACS Nano doi: 10.1021/acsnano.2c02540 contributor: fullname: Zhao – volume: 219 start-page: 1244 year: 2022 ident: 10.1016/j.jconrel.2023.05.043_bb0190 article-title: Research progress on natural β-glucan in intestinal diseases publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2022.08.173 contributor: fullname: Han – volume: 40 start-page: 1154 year: 2022 ident: 10.1016/j.jconrel.2023.05.043_bb0020 article-title: Intestine enzyme-responsive polysaccharide-based hydrogel to open epithelial tight junctions for oral delivery of Imatinib against colon cancer publication-title: Chin. J. Polym. Sci. doi: 10.1007/s10118-022-2726-0 contributor: fullname: Wang – volume: 9 start-page: 7458 year: 2019 ident: 10.1016/j.jconrel.2023.05.043_bb0030 article-title: Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer publication-title: Theranostics doi: 10.7150/thno.38081 contributor: fullname: Han – volume: 159 start-page: 39 year: 2017 ident: 10.1016/j.jconrel.2023.05.043_bb0075 article-title: Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2016.12.009 contributor: fullname: Kang – volume: 17 start-page: 1666 year: 2011 ident: 10.1016/j.jconrel.2023.05.043_bb0090 article-title: Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v17.i13.1666 contributor: fullname: Sipos – volume: 316 start-page: 663 year: 2017 ident: 10.1016/j.jconrel.2023.05.043_bb0110 article-title: Efficient production of hybrid bio-nanomaterials by continuous microchannel emulsification: dye-doped SiO2 and Au-PLGA nanoparticles publication-title: Chem. Eng. J. doi: 10.1016/j.cej.2017.02.003 contributor: fullname: Larrea – volume: 42 start-page: 227 year: 2022 ident: 10.1016/j.jconrel.2023.05.043_bb0005 article-title: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment publication-title: Med. Res. Rev. doi: 10.1002/med.21809 contributor: fullname: Khan – volume: 33 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0100 article-title: A noninvasive gut-to-brain oral drug delivery system for treating brain tumors publication-title: Adv. Mater. doi: 10.1002/adma.202100701 contributor: fullname: Miao – volume: 134 start-page: 1296 year: 2008 ident: 10.1016/j.jconrel.2023.05.043_bb0010 article-title: Systemic treatment of colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.02.098 contributor: fullname: Wolpin – volume: 78 start-page: CT095 year: 2018 ident: 10.1016/j.jconrel.2023.05.043_bb0035 article-title: Abstract CT095: Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients (pts) bearing MGMT methylation publication-title: Cancer Res. doi: 10.1158/1538-7445.AM2018-CT095 contributor: fullname: Morano – volume: 89 start-page: 58 year: 2009 ident: 10.1016/j.jconrel.2023.05.043_bb0210 article-title: No effect of added β-glucan or of fructooligosaccharide on appetite or energy intake publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.2008.26701 contributor: fullname: Peters – volume: 10 start-page: 1743 year: 2015 ident: 10.1016/j.jconrel.2023.05.043_bb0130 article-title: Specifically targeted delivery of protein to phagocytic macrophages publication-title: Int. J. Nanomedicine contributor: fullname: Yu – volume: 6 start-page: 2100951 year: 2022 ident: 10.1016/j.jconrel.2023.05.043_bb0025 article-title: Temulence therapy to orthotopic colorectal tumor via oral administration of fungi-based acetaldehyde generator publication-title: Small Methods doi: 10.1002/smtd.202100951 contributor: fullname: Zhang – volume: 43 start-page: 217 year: 2011 ident: 10.1016/j.jconrel.2023.05.043_bb0015 article-title: MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines publication-title: Acta Biochim. Biophys. Sin. doi: 10.1093/abbs/gmq125 contributor: fullname: Chai – volume: 458 start-page: 1180 year: 2009 ident: 10.1016/j.jconrel.2023.05.043_bb0125 article-title: Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation publication-title: Nature doi: 10.1038/nature07774 contributor: fullname: Aouadi – volume: 31 start-page: 2009733 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0170 article-title: Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.202009733 contributor: fullname: Fan – volume: 9 start-page: 1 year: 2019 ident: 10.1016/j.jconrel.2023.05.043_bb0135 article-title: Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release publication-title: Sci. Rep. contributor: fullname: Chen – volume: 8 start-page: 10383 year: 2014 ident: 10.1016/j.jconrel.2023.05.043_bb0045 article-title: Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors publication-title: ACS Nano doi: 10.1021/nn503735w contributor: fullname: Stephen – volume: 10 start-page: 97 year: 1997 ident: 10.1016/j.jconrel.2023.05.043_bb0095 article-title: Role of organized intestinal lymphoid aggregates in intestinal regeneration publication-title: J. Investig. Surg. doi: 10.3109/08941939709032139 contributor: fullname: Saxena – volume: 147 year: 2020 ident: 10.1016/j.jconrel.2023.05.043_bb0080 article-title: Chitosan as a coating material for nanoparticles intended for biomedical applications publication-title: React. Funct. Polym. doi: 10.1016/j.reactfunctpolym.2019.104459 contributor: fullname: Frank – volume: 32 year: 2020 ident: 10.1016/j.jconrel.2023.05.043_bb0205 article-title: Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis publication-title: Redox Biol. doi: 10.1016/j.redox.2020.101495 contributor: fullname: Wang – volume: 253 year: 2021 ident: 10.1016/j.jconrel.2023.05.043_bb0200 article-title: Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2020.117255 contributor: fullname: Zheng – volume: 7 start-page: 20890 year: 2016 ident: 10.1016/j.jconrel.2023.05.043_bb0115 article-title: The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells publication-title: Oncotarget doi: 10.18632/oncotarget.7896 contributor: fullname: Xu – volume: 22 start-page: 1 year: 2016 ident: 10.1016/j.jconrel.2023.05.043_bb0145 article-title: The simulation of UV spectroscopy and electronic analysis of temozolomide and dacarbazine chemical decomposition to their metabolites publication-title: J. Mol. Model. doi: 10.1007/s00894-016-3133-7 contributor: fullname: Khalilian – volume: 93 start-page: 381 year: 2016 ident: 10.1016/j.jconrel.2023.05.043_bb0120 article-title: Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2016.08.080 contributor: fullname: Thakur |
SSID | ssj0005347 |
Score | 2.4954243 |
Snippet | Temozolomide (TMZ) is an oral DNA-alkylating drug used in colorectal cancer (CRC) chemotherapy. In this work, we proposed a safe and biomimetic platform for... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 347 |
SubjectTerms | Colorectal cancer therapy Oral drug delivery system PLGA Temozolomide Tumor-specific accumulation Yeast shell wall |
Title | Yeast cell membrane-camouflaged PLGA nanoparticle platform for enhanced cancer therapy |
URI | https://dx.doi.org/10.1016/j.jconrel.2023.05.043 https://www.ncbi.nlm.nih.gov/pubmed/37277054 https://search.proquest.com/docview/2823042762 |
Volume | 359 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSyMxEB-0vtyLnHp39vwggvhkWptk0_SxyGnvQymcHt5TyOYDLXZbavvQF_92J5vdK_cggrDssgshYWZ25jeZjwAcW45Sa7yimWOeCtsN1ATFKVpOpZwVIohYnHx1LQe34sdddrcG53UtTEyrrHR_0umltq6-tCtqtqcPD-3fCFYUj1FBHsNhMluHDTRHQjRgo__95-B6lenBRaqalorGAatCnvaoNUK3c-ZjEILxsoen4K-ZqNcgaGmKLj7CZoUhST8tcwvWfLENJ8PUhHp5Sm5WNVVPp-SEDFftqZc78OdvPK6HxB17MvZj9JYLT60ZTxbhEZWLI8Nfl31SmALd6TQDmT6aeQS3BG_EF_dl1gCx8TEjqYJr-QluL77dnA9odboCtUiEOc26XKoQLJPWWdPLO6GHrnLOMsfxkjIoGfKAAA8Z1jHO855C99BKx10QmbD8MzSKSeF3gYiOZwax4Zl3XhiO_nluGHc-Mz3pGFNNaNUE1dPUREPX2WUjXXFARw7os0wjB5qgarLr_6RBo6J_a-hRzSaNf0okJpJxsnjSrIwpMtT-TfiS-PdvNRxhXBfR69f3T7wHH-JbSuXdh8Z8tvAHCFjm-SGst547h5VYvgD7sOvG |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB5S59BeSvp204cKJacojvWyfDShqdM4xlCnpCeh1YPGxGvj2Af_-45WuzU9hEJh2YVdhMTM7Mw3mocAPjuOUmuDptKzQIXrRWqj5hQtp9beCRFFKk6-Gqvhtfh2I2_24KyphUlplbXuzzq90tb1m05Nzc7y9rbzHcGK5ikqyFM4TMlHsC9krytasD-4uByOd5keXOSqaaVpGrAr5OnMTmbodq5CCkIwXvXwFPwhE_UQBK1M0fkBPK0xJBnkZT6DvVA-h6NJbkK9PSbTXU3V_TE5IpNde-rtC_jxMx3XQ9KOPZmHOXrLZaDOzhebeIfKxZPJ6OuAlLZEdzrPQJZ3dp3ALcEbCeWvKmuAuPRYkVzBtX0J1-dfpmdDWp-uQB0SYU1ljysdo2PKeWf7RTf20VUumPQcL6WiVrGICPCQYV3rA-9rdA-d8txHIYXjr6BVLsrwBojoBmYRG54GH4Tl6J8XlnEfpO0rz5huw0lDULPMTTRMk102MzUHTOKAOZUGOdAG3ZDd_CUNBhX9v4Z-athk8E9JxEQyLjb3hlUxRYbavw2vM__-rIYjjOshen37_xN_hMfD6dXIjC7Gl4fwJH3Jab3voLVebcJ7BC_r4kMtnL8Bq4XtuA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Yeast+cell+membrane-camouflaged+PLGA+nanoparticle+platform+for+enhanced+cancer+therapy&rft.jtitle=Journal+of+controlled+release&rft.au=He%2C+Yu&rft.au=Chen%2C+Qi-Wen&rft.au=Yu%2C+Jin-Xin&rft.au=Qin%2C+Si-Yong&rft.date=2023-07-01&rft.eissn=1873-4995&rft.volume=359&rft.spage=347&rft_id=info:doi/10.1016%2Fj.jconrel.2023.05.043&rft_id=info%3Apmid%2F37277054&rft.externalDocID=37277054 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |